Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Capsaicin Induces Apoptosis in Human Small Cell Lung Cancer Via the TRPV6 Receptor and the Calpain Pathway
Apoptosis, 19(8):1190-1201
Lectura recomendada:
An Open-Label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients With Scleroderma-Associated Interstitial Lung Disease: The LOTUSS Trial
Journal of Rheumatology,
Lectura recomendada:
Inflammatory Mechanisms in Patients With Chronic Obstructive Pulmonary Disease
The Journal of Allergy and Clinical Immunology, 138(1):16-27
¿Cuáles son los efectos de la N-acetilcisteína (NAC)?
Introducción:
La N-acetilcisteína es un agente mucolítico que reduce el riesgo de exacerbaciones agudas en los pacientes con bronquitis crónica o enfermedad pulmonar obstructiva crónica.
Lectura recomendada:
Influence of N-Acetylcysteine on Chronic Bronchitis or COPD Exacerbations: A Meta-Analysis
European Respiratory Review, 24(137):451-461
Lectura recomendada:
The COPD Assessment Test: What do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages
Chest, 149(2):413-425
Lectura recomendada:
Vascular Calcification in Patients With Nondialysis CKD Over 3 Years
Clinical Journal of the American Society of Nephrology, 10(4):654-666
Lectura recomendada:
Clinical Implications of Riociguat Pharmacokinetics and Pharmacodynamics: Introduction to the Riociguat Clinical Pharmacology Supplement
Pulmonary Circulation, 6(S1):1-4
Lectura recomendada:
Vascular Calcification in Patients With Nondialysis CKD Over 3 Years
Clinical Journal of the American Society of Nephrology, 10(4):654-666
Lectura recomendada:
Effects of Vitamin D Levels on Asthma Control and Severity in Pre-School Children
European Review for Medical and Pharmacological Sciences, 20(1):26-36
Lectura recomendada:
Pirfenidone for Idiopathic Pulmonary Fibrosis: Analysis of Pooled Data From Three Multinational Phase 3 Trials
European Respiratory Journal, 47(1):243-253